Abstract
The performance of fludeoxyglucose F 18 (FDG)-PET/computed tomography (CT) in the initial and follow-up evaluation of patients with melanoma is well established. Groups are beginning to investigate whether the inclusion of FDG-PET/CT into a staging or surveillance algorithm results in an improvement in patient outcome and whether such an imaging program would be cost-effective.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 243-254 |
| Number of pages | 12 |
| Journal | PET Clinics |
| Volume | 10 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 1 2015 |
Keywords
- Melanoma
- Outcomes
- PET/CT
- Surveillance
ASJC Scopus subject areas
- Radiation
- Radiology Nuclear Medicine and imaging
Fingerprint
Dive into the research topics of 'PET/computed tomography and patient outcomes in melanoma'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS